Individual monitoring of thiopurine and methotrexate treatment
Baslund, B.; Dalhoff, K.P.; Schmiegelow, K.
Ugeskrift for Laeger 167(20): 2177-2179
2005
ISSN/ISBN: 0041-5782 PMID: 15987078 Document Number: 592409
Document emailed within 1 workday
Related Documents
Schmiegelow, K.; Hertz, H. 1998: Thiopurine treatment. Significance of pharmacogenetic polymorphism Ugeskrift for Laeger 160(8): 1189-1191van Dooren-Greebe, R.J.; Kuijpers, A.L.; Termorshuizen, F.; van de Kerkhof, P.C. 1995: Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate Acta Dermato-Venereologica 75(5): 393-396
Jones, K.W.; Patel, S.R. 2000: A family physician's guide to monitoring methotrexate American Family Physician 62(7): 1607
Osterwalder, J.J.; Knoblauch, A. 1991: Randomized and controlled single-case study--a scientific method for individual and difficult therapy decisions in clinical practice exemplified with methotrexate use in asthma Schweizerische Rundschau für Medizin Praxis 80(43): 1168-1172
Ermilova, A.P.; Margulis, U.I.; Khrushch, V.T. 1973: Methodical problems in individual monitoring of internal radiation due to introduction of Po 210 into the body Gigiena i Sanitariia 38(9): 62-65
Perera, R.; Heneghan, C.; Fitzmaurice, D.; Perera, R.; Heneghan, C.; Fitzmaurice, D.; Alonso-Coello, P.; Ansell, J.; Beyth, R.; Christensen, T.D.; Deeks, J.; Didjurgeit, U.; Garcia-Alamino, J.M.; Gardiner, C.; Hasenkam, M.; Hemkens, L.; Horstkotte, D.; Kaatz, S.; Kamali, F.; Knight, E.; Levi, M.; Meats, E.; Menéndez-Jándula, B.; Sidhu, P.; Siebenhofer, A.; Souto, J.C.; Van der Meer, F.; Völler, H.; Ward, A.M.; Glasziou, P. 2008: Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol Journal of Heart Valve Disease 17(2): 233-238
Domański, T.; Kluszczyński, D.; Olszewski, J.; Chruscielewski, W. 1989: Field monitoring versus individual miner dosimetry of radon daughter products in mines Polish Journal of Occupational Medicine 2(2): 147-160
Pampalon, R.; Hamel, D.; Gamache, P. 2009: A comparison of individual and area-based socio-economic data for monitoring social inequalities in health Health Reports 20(4): 85-94
Cremaschini, M.; Moretti, R.; Valoti, M.; Barbaglio, G.; Arnoldi, M.; Bigoni, F.; Guaschi, E.; Merisi, F.; Passera, P.; Rebba, A.; Signori, M.; Tomio, M.; Baldasseroni, A.; Carrer, P.; Costa, G.; Dal Cason, L.; De Santa, A.; Gelatti, U.; Gili, C.; Magrini, A.; Masanotti, G.; Mosconi, G.; Pagliaro, G.; Ramistella, E.; Ronchin, M.; Riboldi, L.; Sartorelli, P.; Scafato, E.; Serra, A.; Tinghino, B.; Valente, P.; Valetto, M.Rosa.; Vigna, L. 2017: Delphi consensus on the monitoring tools of main individual risk factors for chronic diseases by the company doctor La Medicina del Lavoro 108(1): 24-32
Sevelda, P.; Dittrich, C.; Salzer, H.; Pateisky, N.; Spona, J. 1986: Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125 Cancer Detection and Prevention 9(5-6): 521-528
Mielke, H.; Schulz, J.; Beuche, W.; Labitzke, H. 1981: Monitoring of udder health by quarterwise measurement of initial milking samples for electric conductivity--results of serial examinations of individual animals and herds Archiv für Experimentelle Veterinarmedizin 35(2): 259-276
Iqbal, M.P.; Malik, I.; Mehboobali, N. 1992: Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy JPMA. Journal of the Pakistan Medical Association 42(8): 193-196
Cadman, E.C.; Glick, J.H.; Cross, J.; Horton, J.; Taylor, S.G. 1984: Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer Cancer Treatment Reports 68(6): 877-879
Carballada, F.; Boquete, M.; Núñez, R.; Lombardero, M.; de la Torre, F. 2010: Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens Journal of Investigational Allergology and Clinical Immunology 20(6): 506-513
Kinahan, J.J.; Otten, M.; Grindey, G.B. 1979: Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine Cancer Research 39(9): 3531-3539
Laish, I.; Pomeranz, I.; Kitay-Cohen, Y.; Konikof, F. 2012: Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease Harefuah 151(12): 692
Cobo-Ibáñez, T.; Muñoz-Fernández, S.; Hidalgo-Barrero, V.; Martín-Mola, E. 2006: Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment Medicina Clinica 126(1): 34-35
Lee, M.H.; Huang, Y.M.; Sartorelli, A.C. 1978: Alkaline phosphatase activities of 6-thiopurine-sensitive and -resistant sublines of Sarcoma 180 Cancer Research 38(8): 2413-2418
Schlegel, H.B.; Poe, M.; Hoogsteen, K. 1981: Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate Molecular Pharmacology 20(1): 154-158
Woodson, L.C.; Dunnette, J.H.; Weinshilboum, R.M. 1982: Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies Journal of Pharmacology and Experimental Therapeutics 222(1): 174-181